Dr Marla Crea Farrell, MD | |
1710 Mulberry St, Scranton, PA 18510-2336 | |
(570) 969-7313 | |
(570) 969-7387 |
Full Name | Dr Marla Crea Farrell |
---|---|
Gender | Female |
Speciality | Pediatrics |
Location | 1710 Mulberry St, Scranton, Pennsylvania |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1356687982 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208000000X | Pediatrics | MD053382L (Pennsylvania) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Marla Crea Farrell, MD 1710 Mulberry St, Scranton, PA 18510-2336 Ph: (570) 969-7313 | Dr Marla Crea Farrell, MD 1710 Mulberry St, Scranton, PA 18510-2336 Ph: (570) 969-7313 |
News Archive
Sonographically-guided alcohol injections has a high success rate and is well tolerated by patients with Morton?s neuroma, a common cause of foot pain, according to a recent study conducted by researchers at the Royal National Orthopaedic Hospital and Kingston Hospital NHS Trust in Middlesex, United Kingdom.
Researchers at Linköping University have made a discovery that could contribute to developing new vaccines and treatment alternatives for tuberculosis in the future. The results have been published in Scientific Reports, a sister journal to the highly respected periodical Nature.
Bright light arouses us. Bright light makes it easier to stay awake. Very bright light not only arouses us but is known to have antidepressant effects. Conversely, dark rooms can make us sleepy. It's the reason some people use masks to make sure light doesn't wake them while they sleep.
Oncolytics Biotech Inc., a clinical-stage biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics, today announced that the U.S. Food and Drug Administration has granted Orphan Drug Designation for its lead product candidate, REOLYSIN, for the treatment of primary peritoneal cancers.
In a paper published in the July 11 online issue of Science Translational Medicine, researchers at the University of California, San Diego School of Medicine have identified two key regulatory proteins critical to clearing away misfolded proteins that accumulate and cause the progressive, deadly neurodegeneration of Huntington's disease.
› Verified 9 days ago
Ms. Alana Rickard, D.O Pediatrics Medicare: Medicare Enrolled Practice Location: 531 Mt Pleasant Dr, Scranton, PA 18503 Phone: 570-342-8500 Fax: 570-558-2290 | |
Marie S Lena, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 531 Mt Pleasant Dr, Scranton, PA 18503 Phone: 570-342-8500 Fax: 570-558-2290 | |
Mr. Vincent Luciano Ross, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 442 N Main Ave, Scranton, PA 18504 Phone: 570-347-5605 Fax: 570-347-5606 | |
Dr. Michael Rogan, MD Pediatrics Medicare: May Accept Medicare Assignments Practice Location: 2232 Pittston Ave, Scranton, PA 18505 Phone: 570-340-2100 | |
Violeta Marina Lizano, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 201 Smallacombe Dr, Scranton, PA 18508 Phone: 570-961-0171 Fax: 570-207-2411 | |
Christine Burke, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 959 Wyoming Ave, Scranton, PA 18509 Phone: 570-344-9684 Fax: 570-969-0968 | |
Dr. Elizabeth Escalante, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 700 Quincy Ave, 5th Fl, Scranton, PA 18510 Phone: 570-770-7546 Fax: 570-770-7545 |